Search results

Filter (7 in use)

Type 6 selected

  • Remove filter for guidance
  • Remove filter for NICE advice (1)
  • Remove filter for NICE Pathways (6)
  • Remove filter for Local practice (1)
  • Remove filter for news
  • Remove filter for quality standards

Last updated 1 selected

  • Filter by Last 3 months
  • Remove filter for Last 6 months
  • Filter by Last year
  • Filter by Last 3 years

Advice programme

  • Filter by Medtech innovation briefings (1)

1 result for ibd

Sorted by Date . | Sort by Relevance

  • guidance Remove guidance filter
  • NICE advice Remove NICE advice filter
  • NICE Pathways Remove NICE Pathways filter
  • Local practice Remove Local practice filter
  • news Remove news filter
  • quality standards Remove quality standards filter
  • Last 6 months Remove Last 6 months filter
  1. Faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection (MIB247)

    NICE has developed a medtech innovation briefing (MIB) on faecal microbiota transplant for recurrent or refractory Clostridioides difficile infection.

    Type
    Medtech innovation briefing
    Published
    02 February 2021